Mustang Bio, Inc. (MBIO): Shareholders' Equity
$9.53M
As of 2025-12-31
$7.54M
As of 2026-06-30
-40.9%
3-year compound annual growth
-37.3%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.53M | n/m | 2026-03-19, Balance as of period end |
| 2024-12-31 | -$3.87M | n/m | 2026-03-19, Balance as of period end |
| 2023-12-31 | $123.0K | -99.7% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $46.27M | -58.8% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $112.40M | +14.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $98.44M | +90.6% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $51.65M | +41.9% | 2021-03-24, Balance as of period end |
| 2018-12-31 | $36.40M | -39.2% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $59.83M | +146.5% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $24.28M | n/m | 2018-03-29, Balance as of period end |
| 2015-12-31 | -$4.13M | n/a | 2018-03-29, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | $9.53M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $12.61M | +196.1% |
| Clene Inc. (CLNN) | 2025-12-31 | -$17.59M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | $14.48M | -31.1% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | $6.67M | -65.1% |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $15.78M | -3.3% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $5.61M | +235.0% |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗